| Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses JM Jaynes, R Sable, M Ronzetti, W Bautista, Z Knotts, ... Science translational medicine 12 (530), eaax6337, 2020 | 230 | 2020 |
| Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer MSU Ahmed, AB Salam, C Yates, K Willian, J Jaynes, T Turner, ... International journal of nanomedicine, 6973-6984, 2017 | 58 | 2017 |
| Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c A Abisoye-Ogunniyan, H Lin, A Ghebremedhin, AB Salam, B Karanam, ... Cancer letters 431, 1-10, 2018 | 29 | 2018 |
| A novel CD206 targeting peptide inhibits bleomycin-induced pulmonary fibrosis in mice A Ghebremedhin, AB Salam, B Adu-Addai, S Noonan, R Stratton, ... Cells 12 (9), 1254, 2023 | 26 | 2023 |
| Poziotinib inhibits HER2-mutant–driven therapeutic resistance and multiorgan metastasis in breast cancer R Kalra, CH Chen, J Wang, AB Salam, LE Dobrolecki, A Lewis, C Sallas, ... Cancer Research 82 (16), 2928-2939, 2022 | 9 | 2022 |
| Bounds on two parametric new generalized fuzzy entropy AH Bhat, MAK Baig, A Salam Mathematical Theory and Modeling 6 (7), 7-17, 2016 | 5 | 2016 |
| Integrating pharmacogenomics data-driven computational drug prediction with single-cell RNAseq to demonstrate the efficacy of a NAMPT inhibitor against aggressive, taxane … S Mazumder, T Mitra Ghosh, UK Mukherjee, S Chakravarti, F Amiri, ... Cancers 14 (23), 6009, 2022 | 4 | 2022 |
| Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors RK Anchoori, L George, SH Tseng, B Lam, S Polkampally, AD Amiano, ... Plos one 16 (9), e0256937, 2021 | 4 | 2021 |
| Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer CC Parker, A Bin Salam, PN Song, C Gallegos, A Hunt, C Yates, J Jaynes, ... Molecular Pharmaceutics 20 (5), 2415-2425, 2023 | 3 | 2023 |
| Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and … S Mazumder, TM Ghosh, UK Mukherjee, S Chakravarti, F Amiri, ... bioRxiv, 2022.07. 20.500378, 2022 | 1 | 2022 |
| ACE inhibitor, captopril, attenuates cytopathic effects of herpes simplex virus 1 in SH-SY5Y cells AS Wofford, A Standiford, K Harris, AB Salam, CA Jackson, CN Bradford, ... F1000Research 9 (1122), 1122, 2020 | 1 | 2020 |
| Abstract LB-181: CD133 as a disparity stem cell biomarker in African Americans with late-stage prostate cancer B Adu-Addai, AB Salam, R Amin, H Wang, H Lin, A Ghebremedhin, ... Cancer Research 79 (13_Supplement), LB-181-LB-181, 2019 | 1 | 2019 |
| Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling MSU Ahmed, BD Lord, B Adu Addai, SK Singhal, K Gardner, AB Salam, ... Cancers 15 (8), 2282, 2023 | | 2023 |
| Characterization of Radiolabeled Peptides for PET Imaging of CD206 Positive Macrophages in Cancer C Parker, AB Salam, J Jaynes, A Hunt, C Yates, S Lapi Journal of Nuclear Medicine 63 (supplement 2), 2871-2871, 2022 | | 2022 |
| Synthesis of [18F] MK7246 for beta cell mass imaging C Parker, AB Salam, J Jaynes, C Yates, S Lapi Nuclear Medicine and Biology 108, S40-S41, 2022 | | 2022 |
| Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer SM Kavuri, R Kalra, CH Chen, J Wang, A Bin Salam, L Dobrolecki, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P2-13-24: Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer SM Kavuri, R Kalra, CH Chen, J Wang, AB Salam, L Dobrolecki, A Lewis, ... Cancer Research 82 (4_Supplement), P2-13-24-P2-13-24, 2022 | | 2022 |
| Novel synthetic peptide targets CD206 receptor promoting the repolarization of prostate cancer (PCa) TAMs and increase the efficacy of conventional prostate cancer therapeutic AB Salam, B Adu-Addai, H Lin, A Ghebremedhin, J White, R Amin, ... Cancer Research 78 (13_Supplement), 4062-4062, 2018 | | 2018 |
| Molecular Modeling Studies of Novel Receptor-targeted Peptides in the Treatment of Prostate Cancer ABA Salam Tuskegee University, 2017 | | 2017 |
| Molecular modeling of novel peptide-receptor interaction for targeted drug delivery of prostate cancer A Salam, V Hembrick, J Jaynes, T Turner, M Abdalla Cancer Research 76 (14_Supplement), 2170-2170, 2016 | | 2016 |
Clayton YatesJohns Hopkins School of MedicineVerified email at jhmi.edu
